Everything you need to understand before starting a GLP-1 weight loss program through Tmates — clinical evidence, how to choose between options, and realistic expectations.
GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that work by mimicking a gut hormone naturally secreted after eating. Through Tmates telehealth's weight loss category, two GLP-1 options are available: compounded semaglutide at $249/month and compounded tirzepatide at $297/month. Both are available in injectable and oral formulations at the same price, with all dosages included in one flat rate.
GLP-1 medications work through three primary mechanisms: hypothalamic appetite suppression (directly reducing hunger drive), slowed gastric emptying (food stays in the stomach longer, extending satiety), and elimination of food noise (the persistent mental preoccupation with eating that makes dieting exhausting). These pharmacological effects produce caloric reduction naturally — patients eat less because they want less food, not because they're forcing willpower against persistent hunger.
Semaglutide (single GLP-1 receptor agonist) produced 14.9% average body weight loss in STEP-1 at 68 weeks. Tirzepatide (dual GLP-1/GIP receptor agonist) produced 22.5% average weight loss in SURMOUNT-1 at 72 weeks. The dual mechanism explains tirzepatide's superior results — GIP receptor agonism adds insulin sensitivity improvement and enhanced fat metabolism beyond GLP-1 alone. For a detailed head-to-head: semaglutide vs tirzepatide comparison.
Budget consideration: at 12-month bundle pricing, semaglutide is $158/mo and tirzepatide is $167/mo — only $9/month difference for meaningfully better clinical outcomes. For patients committing to a full year, tirzepatide's 7.6 percentage point clinical advantage at modest additional cost is typically the better choice for maximum results.
BMI ≥30 (obesity), or BMI ≥27 (overweight) with at least one weight-related health condition: type 2 diabetes, hypertension, high cholesterol, sleep apnea, cardiovascular disease, prediabetes, PCOS, or metabolic syndrome. Condition-specific guides: obesity (BMI 30+), PCOS weight loss, prediabetes, metabolic syndrome. Absolute contraindications: personal or family history of MTC or MEN2; pregnancy. Your Tmates physician reviews your full health history during intake.
Tmates' compounded semaglutide and tirzepatide contain the same active molecules as brand-name Wegovy® and Zepbound® but are not FDA-approved finished products. Compounding pharmacies are regulated by state pharmacy boards and (for 503B facilities) the FDA. Tmates discloses this explicitly. Brand-name options: Wegovy® Rx service ($99/mo) and Zepbound® Rx service ($99/mo) for prescription management of FDA-approved medications.
Start your Tmates program today — free shipping, cancel anytime, full refund if not approved.
Get Started with Tmates →Read: complete GLP-1 medications guide, month-by-month journey, full Tmates review 2026, complete pricing guide. Compare platforms: vs Medvi · vs TrimRx.
Doctor-supervised GLP-1 programs from $249/mo. Free shipping. Full refund if not approved.
Check Eligibility Free →